Flaxseed oil reduces the growth of human breast tumors (Mcf-7) at high levels of circulating estrogen

Molecular Nutrition and Food Research

Volumn 54, Issue 10, 2010, Pages 1414-1421

  Truan, Jennifer S ^a   Chen, Jian Min ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Athymic nude mice; Breast cancer; Flaxseed oil; MCF 7 xenografts; linolenic acid

Indexed keywords

ANTINEOPLASTIC AGENT; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR; HER2 PROTEIN, HUMAN; LINSEED OIL; OMEGA 3 FATTY ACID;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD; BREAST TUMOR; CELL PROLIFERATION; CHEMISTRY; DOWN REGULATION; DRUG EFFECT; DRUG SCREENING; FEMALE; FLAX; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHYTOTHERAPY; PREMENOPAUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; ESTRADIOL; FATTY ACIDS, OMEGA-3; FEMALE; FLAX; HUMANS; LINSEED OIL; MICE; MICE, NUDE; PHYTOTHERAPY; PREMENOPAUSE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77955052781     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900521     Document Type: Article

References (41)

1. Cunnane, S. C., Ganguli, S., Menard, C., Liede, A. C. et al., High ∝-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Brit. J. Nutr. 1993, 69, 443–453.
2. Thompson, L. U., Boucher, B. A., Liu, Z., Cotterchio, M., Kreiger, N., Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr. Cancer. 2006, 54, 184–201.
3. Adlercreutz, H., Lignans and human health. Crit. Rev. Clin. Lab. Sci. 2007, 44, 483–525.
4. Mazur, W., Phytoestrogen content in foods. Baillieres Clin. Endocrinol. Metab. 1998, 12, 729–742.
5. Saggar, J. K., Chen, J. M., Corey, P., Thompson, L. U., Potential mechanisms whereby the lignan or oil components of flaxseed, alone or in combination with tamoxifen exert their effect on breast cancer. FASEB J. 2008, 22, 311.3.
6. Power, K. A., Chen, J. M., Saarinen, N. M., Thompson, L. U., Changes in biomarkers of estrogen receptor and growth factor signaling pathways in MCF-7 tumors after short-and long-term treatment with soy and flaxseed. J. Steroid Biochem. Mol. Biol. 2008, 112, 13–19.
7. Chen, J. M., Hui, E., Ip, T., Thompson, L. U., Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (MCF-7) in nude mice. Clin. Cancer Res. 2004, 10, 7703–7711.
8. Saarinen, N. M., Power, K. A., Chen, J. M., Thompson, L. U., Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts. Int. J. Cancer 2006, 119, 925–931.
9. Saggar, J. K., Chen, J. M., Corey, P., Thompson, L. U., Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor-and growth factor-signaling pathways. Mol. Nutr. Food. Res. 2009, 54, 415–425.
10. Chen, J. M., Power, K. A., Mann, J., Cheng, A., Thompson, L. U., Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by down-regulating the expression of estrogen related gene products and signal transduction pathways. Nutr. Cancer 2007, 58, 162–170.
11. Chen, J. M., Power, K. A., Mann, J., Cheng, A., Thompson, L. U., Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp. Biol. Med. 2007, 232, 1071–1080.
12. Chen, J. M., Stavro, P. M., Thompson, L. U., Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr. Cancer 2002, 43, 187–192.
13. Thompson, L. U., Chen, J. M., Li, T., Strasser-Weippl, K., Goss, P. E., Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin. Cancer Res. 2005, 11, 3828–3835.
14. Jungestrom, M. B., Thompson, L. U., Dabrosin, C., Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin. Cancer Res. 2007, 13, 1061–1067.
15. 0 s Health 2007, 1(4).
16. Reeves, P. G., Nielsen, F. H., Fahey, G. C., Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123, 1939–1951.
17. Wang, L., Chen, J. M., Thompson, L. U., The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenografts is attributed to both its lignan and oil components. Int. J. Cancer 2005, 116, 793–798.
18. Dabrosin, C., Chen, J., Wang, L., Thompson, L. U., Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett. 2002, 185, 31–37.
19. Ealey, K. N., El-Sohemy, A., Archer, M. C., Effects of dietary conjugated linoleic acid on the expression of uncoupling proteins in mice and rats. Lipids 2002, 37, 853–861.
20. Folch, J., Lees, M., Sloane Stanley, G. H., A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497–509.
21. Chen, C., Liu, Z., Ouellet, M., Calon, F., Bazinet, R., Rapid β-oxidation of eicosapentaenoic acid in mouse brain: An in situ study. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80, 157–163.
22. Santen, R. J., Song, R. X., McPherson, R., Kumar, R. et al., The role of mitogen-activated protein (MAP) kinase in breast cancer. J. Steroid Biochem. Mol. Biol. 2002, 80, 239–256.
23. Kennedy, S. G., Wagner, A. J., Conzen, S. D., The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 1997, 11, 701–713.
24. De Chiara, G., Marcocci, M. E., Torcia, M., Lucibello, M. et al., Bcl-2 phosphorylation by p38 MAPK: Identification of target sites and biologic consequences. J. Biol. Chem. 2006, 281, 21353–21361.
25. Pugazhenthi, S., Nesterova, A., Sable, C., Heidenreich, K. A. et al., Akt/Protein Kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J. Biol. Chem. 2000, 275, 10761–10766.
26. Lee, Y. R., Park, J., Yu, H. N., Kim, J. S. et al., Up-regulation of P13K/Akt signaling by 17 beta-estradiol through activation of estrogen receptor-alpha but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Biochem. Biophys. Res. Commun. 2005, 336, 1221–1226.
27. Callagy, G. M., Webber, M. J., Pharoah, P. D., Caldas, C., Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer. BMC Cancer 2008, 8, 153.
28. Kerbel, R. S., Tumor angiogenesis: past, present and the near future. Carcinogenesis 2000, 21, 505–515.
29. Menendez, J. A., Vazquez-Martin, A., Ropero, S., Colomer, R. et al., HER2 (erb B-2)-targeted effects of the ω-3 polyunsaturated. Fatty acid ∝-linolenic acid (ALA; 18:3 n-3) in breast cancer cells: the fat features of the Mediterranean diet as an anti-HER2 cocktail. Clin. Transl. Oncol. 2006, 8, 812–820.
30. Brenna, J. T., Efficiency of conversion of a-linolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5, 127–132.
31. Serraino M. R., Thompson, L. U., Cunnane, S. C., Effect of low level flaxseed supplementation on the fatty acid composition of mammary glands and tumors in rats. Nutr. Res. 1992, 12, 767–772.
32. Thompson, L. U., Rickard, S. E., Orcheson, L. J., Seidl, M. M., Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 1996, 17, 1373–1376.
33. Schley, P. D., Brindley, D. N., Field, C. J., (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J. Nutr. 2007, 137, 548–553.
34. Stoll, B. A., n-3 fatty acids and lipid peroxidation in breast cancer inhibition. Brit. J. Nutr. 2002, 87, 193–198.
35. Menendez, J. A., Ropero, S., Mehmi, I., Atlas, E. et al., Overexpression and hyperactivity of breast cancer-asso-ciated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal ∝-linolenic and ϒ-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis. Int. J. Oncol. 2004, 24, 1369–1383.
36. Kim, J. B., O’Hare, M. J., Stein, R., Models of breast cancer: Is merging human and animal models the future? Breast Cancer Res. 2004, 6, 22–30.
37. Osborne, C. K., Athymic nude mouse model for the study of new antioestrogens in breast cancer. Breast J 1996, 5, 181–185.
38. Rygaard, J., Povlsen, C. O., The nude mouse vs. the hypothesis of immunological surveillance. Transplant Rev. 1976, 28, 43–61.
39. Furr, B. J. A., Jordan, V. C., The pharmacology and clinical uses of tamoxifen. Pharmacol. Therapeut. 1984, 25, 127–205.
40. Yue, W., Brodie, A., MCF-7 human breast carcinomas in nude mice as a model for evaluating aromatase inhibitors. J. Steroid Biochem. Mol. Biol. 1993, 44, 671–673.
41. Cohen, L. A., Thompson, D. O., Choi, K., Karmali, R. A., Rose, D. P., Dietary fat and mammary cancer. II. Modulation of serum and tumor lipid composition and tumor prostaglandins by different dietary fats: association with tumor incidence patterns. J. Natl. Cancer Inst. 1986, 77, 43–51.